You have been told that bipolar disorder is a medical illness treated with medication, which is true, and then left to work out what the hour with a therapist is supposed to accomplish. The trials have an answer, and it is more specific than "support."

The short answer: structured psychological treatment added to medication reduces recurrence. Across 39 randomised trials and 3,863 participants, manualised adjunctive therapies had lower recurrence rates than control treatments — odds ratio 0.56, 95 percent confidence interval 0.43 to 0.74. Two findings inside that are worth acting on. Psychoeducation with guided practice of illness-management skills delivered in a family or group format beat the same content delivered individually, by a wide margin. And no named modality is established as better than another: cognitive behavioural therapy, family-focused therapy and rhythm-focused therapy all move depression, and none of them is the answer for everyone. What these treatments reliably work on is depression, functioning and staying in treatment. What they do not do is replace medication.¹ ²

What the evidence base looks like

Synthesis Scale What it found
Component network meta-analysis, 2021 39 randomised trials, 3,863 participants Manualised treatments beat controls on recurrence, OR 0.56 (0.43–0.74). Group or family delivery of skills-based psychoeducation beat individual delivery, OR 0.12 (0.02–0.94). CBT stabilised depressive symptoms (SMD −0.32); family and interpersonal therapy similar but less precise¹
Systematic review and meta-analysis, 2016 55 trials, 6,010 participants Individual psychological interventions reduced relapse post-treatment (RR 0.66) and at follow-up (RR 0.74) on moderate-quality evidence; collaborative care reduced hospital admissions (RR 0.68). "Much of the evidence was of low or very low quality"²
Cochrane review of early-warning-sign interventions, 2007 11 trials, 6 with usable primary data Time to first recurrence favoured the intervention (hazard ratio 0.57, 95% CI 0.39–0.82); "Mental health services should consider routinely providing EWS interventions to adults with bipolar disorder"³

A caution to carry through the rest of this page: this is not a literature of large, decisive trials. It is a literature of small ones, many with waitlist or unstructured-attention comparators, and the honest reading is that structured adjunctive treatment helps, that the effect on depression is more reliable than the effect on mania, and that no brand has separated from the others.

There is no completed Cochrane review of psychotherapy for bipolar disorder. A protocol was published in 2025; it contains no results. If you read that "a 2025 Cochrane review found…" about psychotherapy for bipolar disorder, it is quoting something that does not exist yet.³

The four approaches, and what each was tested on

Group psychoeducation

Twenty-one sessions of ninety minutes, in a group, on four things: illness awareness, treatment adherence, early detection of prodromal symptoms, and regularity of daily life.⁴

The Barcelona trial randomised 120 people in remission to psychoeducation or unstructured group meetings, alongside standard medication, and followed them for two years. It "significantly reduced the number of relapsed patients and the number of recurrences per patient, and increased the time to depressive, manic, hypomanic, and mixed recurrences."⁵ At five years, with 99 of the 120 still in follow-up: the psychoeducation group had 3.86 recurrences against 8.37, and spent 154 days acutely ill against 586.⁴

That five-year result is the most durable finding in this field. Two honest caveats: the widely quoted two-year percentages come from a review rather than from the trial paper we could read directly, and dropout was higher in the structured arm.⁶

Family-focused therapy

Twenty-one sessions over nine months of psychoeducation, communication training and problem-solving, with the family in the room.

In the primary trial, 101 patients were randomised to family-focused therapy or a less intensive crisis-management condition, both with medication. "Patients undergoing FFT had fewer relapses (11/31, 35%) and longer survival intervals… than patients undergoing CM (38/70, 54%…; hazard ratio, 0.38; 95% confidence interval, 0.20-0.75; P = .003)," and showed "greater reductions in mood disorder symptoms and better medication adherence during the 2 years."⁷ In a separate trial against individual therapy after hospitalisation for mania, patients in family treatment "were less likely to be rehospitalized during the 2-year study period."⁸

Interpersonal and social rhythm therapy

Weekly, then fortnightly, then monthly sessions built around stabilising daily and social rhythms — when you get up, when you eat, when you see people — alongside interpersonal work.

The maintenance trial randomised 175 acutely ill people with bipolar I across four strategies. There was no difference in time to stabilisation. But "participants assigned to IPSRT in the acute treatment phase survived longer without a new affective episode (P = .01), irrespective of maintenance treatment assignment," they had "higher regularity of social rhythms at the end of acute treatment (P<.001)," and increasing rhythm regularity during acute treatment was associated with lower recurrence later (P = .05).⁹

Read that carefully: the benefit attached to when the therapy was delivered, not to whether it continued — and the rhythm-to-recurrence link is an association inside the trial rather than a randomised comparison. It is suggestive and mechanistically interesting, not proof that regularising your schedule prevents episodes.

Cognitive behavioural therapy

The efficacy trial randomised 103 people with frequent relapses despite mood stabilisers to CBT — about fourteen sessions in six months plus two boosters — or control. Over twelve months the CBT group "had significantly fewer bipolar episodes, days in a bipolar episode, and number of admissions."¹⁰ At thirty months, though, "the effect of relapse prevention was mainly in the first year," and CBT "had no significant effect in relapse reduction over the last 18 months."¹¹

Then the large pragmatic trial, 253 patients, and it was null: "More than half of the patients had a recurrence by 18 months, with no significant differences between groups (hazard ratio=1.05; 95% CI 0.74–1.50)."¹² Its much-quoted subgroup result deserves its qualifier: "Post hoc analysis demonstrated a significant interaction (P=0.04) such that adjunctive CBT was significantly more effective than treatment as usual in those with fewer than 12 previous episodes, but less effective in those with more episodes."¹² A post hoc interaction in a trial with a null primary outcome is a hypothesis. "CBT works better early in the illness" is often reported as established; it is not.

What happens when they are compared head to head

The largest comparison embedded three of them inside a national effectiveness study. Two hundred and ninety-three people with bipolar depression were randomised to up to 30 sessions of intensive psychotherapy — family-focused therapy, interpersonal and social rhythm therapy, or CBT — or to collaborative care, a three-session psychoeducational package with a workbook and a video.¹³

  • Year-end recovery: 64.4 percent with intensive psychotherapy against 51.5 percent with collaborative care, hazard ratio 1.47 (95% CI 1.08–2.00, P = .01).
  • People in intensive psychotherapy were 1.58 times more likely to be clinically well in any given month.
  • Median time to recovery among those who recovered: 113 days against 146.
  • By modality: family-focused therapy 76.9 percent (20 of 26), interpersonal and social rhythm therapy 64.5 percent (40 of 62), CBT 60.0 percent (45 of 75). And: "No statistically significant differences were observed in the outcomes of the 3 intensive psychotherapies."¹³

Two things about that table. Family-focused therapy's number rests on 26 people, because only 54.3 percent of the sample had a family member available. And the authors state that the study "was underpowered to detect small effect size differences between each of the intensive modalities" — the modalities would have had to differ by a hazard ratio of 3.23 to show a reliable difference.¹³

One more figure worth knowing before you sign up for anything: participants in the intensive arms received a mean of 14.3 of the 30 scheduled sessions.¹³ The dose people actually take is about half the dose on the protocol, and the results above are what that produced.

Sleep, and why it is treatment

The one randomised trial of insomnia treatment in bipolar disorder adapted cognitive behavioural therapy for insomnia for people with bipolar I and compared it with psychoeducation. Over six months of follow-up, the treated group "had fewer days in a bipolar episode relative to the PE group (3.3 days vs. 25.5 days)," and "a significantly lower hypomania/mania relapse rate (4.6% vs. 31.6%) and a marginally lower overall mood episode relapse rate (13.6% vs. 42.1%)."¹⁴

Those numbers are striking and the study is a pilot with 58 participants, eight sessions, and a merely marginal effect on overall relapse. It is the best evidence there is that sleep is a lever rather than a symptom, and it is not enough to call it settled. The printable mood and sleep log →

What the guideline asks for

The UK's guideline does not use the word psychoeducation. What it requires is a "structured psychological intervention (individual, group or family), which has been designed for bipolar disorder and has a published evidence-based manual describing how it should be delivered, to prevent relapse or for people who have some persisting symptoms between episodes."¹⁵

And it specifies the contents, which doubles as a checklist for judging a programme:¹⁵

  • information about bipolar disorder
  • the impact of thoughts and behaviour on mood and relapse
  • self-monitoring of mood, thoughts and behaviour
  • relapse risk, distress, and how to improve functioning
  • plans for relapse management and staying well
  • problem-solving for communication patterns and functional difficulties

It also asks for a family intervention where the person lives with or is in close contact with family, and for a written risk-management plan naming triggers, early warning signs, an agreed response, and who to contact.¹⁵ ¹⁶

Choosing something in California

  • Ask which manual. "I use CBT with bipolar clients" and "I run a manualised relapse-prevention programme for bipolar disorder" are different products. The guideline standard is a published manual.¹⁵
  • Prefer a group or family format for the psychoeducation component, if one is reachable. That is the one delivery-format finding with a real effect size behind it.¹
  • Ask what gets monitored and how. Self-monitoring of mood is in the guideline's required contents, and the early-warning-sign literature is where the Cochrane-level evidence sits.³ ¹⁵
  • Ask whether they will talk to your prescriber. Every trial on this page was psychotherapy added to medication.
  • Expect about six to nine months, and expect the sessions to be structured rather than open-ended.
  • If a plan denies it, that is appealable and the regulator's review is free. Appeal a denial → · If nobody in-network has an opening →
  • Bring the family in if you can. Loving someone with bipolar disorder →

Q&A

Q: Does therapy work for bipolar disorder? A: Added to medication, yes: across 39 trials and 3,863 participants, manualised adjunctive therapies had lower recurrence than controls, odds ratio 0.56 (95% CI 0.43–0.74).¹ The effect is clearest on depression, functioning and staying in treatment.

Q: Which therapy is best? A: None has separated from the others. The network meta-analysis found comparable outcomes across CBT, family and interpersonal therapies; the head-to-head study inside STEP-BD found "No statistically significant differences… in the outcomes of the 3 intensive psychotherapies."¹ ¹³ What matters more than the brand is that it is structured, manualised, and delivered alongside medication.

Q: Can therapy replace my medication? A: Every trial described here tested therapy in addition to medication. There is no evidence base for substituting it.

Q: Is group therapy really better than individual? A: For psychoeducation with guided skills practice specifically, the network meta-analysis found family or group delivery beat the same content delivered individually, odds ratio 0.12 (95% CI 0.02–0.94).¹ That is one finding from one synthesis, with a very wide interval — but it points the same way as the family-focused trials, and group programmes are usually cheaper and easier to find.

Q: I've had a lot of episodes. Is CBT still worth it? A: The pragmatic trial's post hoc analysis suggested benefit was confined to people with fewer than twelve prior episodes and possibly reversed above that.¹² It is a post hoc finding in a null trial — worth raising with a clinician, not worth treating as a rule about you.

Q: What if my family is not available or not safe to involve? A: Then group psychoeducation is the format with the next-best evidence, and the individual manualised treatments all have trials behind them. Only 54.3 percent of the STEP-BD sample even had a family member available, and the other arms still worked.¹³

Ready to find a structured programme rather than a general therapist? Filter by approach, schedule and payment route → · The full bipolar map → · What to ask on the consult call →

In crisis? Call or text 988 — free, 24/7.

Sources

  1. Miklowitz DJ, Efthimiou O, Furukawa TA, Scott J, McLaren R, Geddes JR, Cipriani A, "Adjunctive psychotherapy for bipolar disorder: a systematic review and component network meta-analysis," JAMA Psychiatry 78(2), 2021, 141–150 — 39 trials, 3,863 participants; "manualized treatments were associated with lower recurrence rates than control treatments (OR, 0.56; 95% CI, 0.43-0.74)"; "Psychoeducation with guided practice of illness management skills in a family or group format was associated with reducing recurrences vs the same strategies in an individual format (OR, 0.12; 95% CI, 0.02-0.94)"; "Cognitive behavioral therapy (SMD, -0.32; 95% CI, -0.64 to -0.01)… were associated with stabilizing depressive symptoms" — pmc.ncbi.nlm.nih.gov.
  2. Oud M, Mayo-Wilson E, Braidwood R, et al., "Psychological interventions for adults with bipolar disorder: systematic review and meta-analysis," British Journal of Psychiatry 208(3), 2016, 213–222 — 55 trials, 6,010 participants; individual psychological interventions and relapse RR 0.66 post-treatment and 0.74 at follow-up; collaborative care and hospital admissions RR 0.68; "Much of the evidence was of low or very low quality thereby limiting our conclusions" — doi.org.
  3. Morriss RK, Faizal MA, Jones AP, Williamson PR, Bolton C, McCarthy JP, "Interventions for helping people recognise early signs of recurrence in bipolar disorder," Cochrane Database of Systematic Reviews 1, 2007, CD004854 — "Time to first recurrence of any type (RE, hazards ratio 0.57, 95% CI 0.39 to 0.82)… favoured the intervention group"; "Mental health services should consider routinely providing EWS interventions to adults with bipolar disorder" — searches to October 2005 — doi.org. The 2025 Cochrane record on this topic (CD015343) is a protocol and contains no results.
  4. Colom F, Vieta E, Sánchez-Moreno J, et al., "Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial," British Journal of Psychiatry 194(3), 2009, 260–265 — 120 people enrolled, 99 completing five years; "21 sessions of 90 min, each aimed at improving four main issues: illness awareness, treatment adherence, early detection of prodromal symptoms and recurrences and lifestyle regularity"; "The psychoeducation group had fewer recurrences (3.86 v. 8.37, F=23.6, P<0.0001)… and they spent less time acutely ill (154 v. 586 days, F=31.66, P=0.0001)" — doi.org.
  5. Colom F, Vieta E, Martinez-Aran A, et al., "A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission," Archives of General Psychiatry 60(4), 2003, 402–407 — 120 outpatients in remission, 21 sessions against 21 unstructured group meetings; "Group psychoeducation significantly reduced the number of relapsed patients and the number of recurrences per patient, and increased the time to depressive, manic, hypomanic, and mixed recurrences" — doi.org.
  6. Miklowitz DJ, "Adjunctive psychotherapy for bipolar disorder: state of the evidence," American Journal of Psychiatry 165(11), 2008, 1408–1419 — the two-year recurrence figures for the Barcelona trial and the higher dropout in the structured arm — pmc.ncbi.nlm.nih.gov.
  7. Miklowitz DJ, George EL, Richards JA, Simoneau TL, Suddath RL, "A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder," Archives of General Psychiatry 60(9), 2003, 904–912 — 101 patients; "Patients undergoing FFT had fewer relapses (11/31, 35%) and longer survival intervals… than patients undergoing CM (38/70, 54%…; hazard ratio, 0.38; 95% confidence interval, 0.20-0.75; P = .003)"; "better medication adherence during the 2 years" — doi.org.
  8. Rea MM, Tompson MC, Miklowitz DJ, Goldstein MJ, Hwang S, Mintz J, "Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial," Journal of Consulting and Clinical Psychology 71(3), 2003, 482–492 — 53 recently hospitalised patients; "those in family-focused treatment were less likely to be rehospitalized during the 2-year study period" — doi.org.
  9. Frank E, Kupfer DJ, Thase ME, et al., "Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder," Archives of General Psychiatry 62(9), 2005, 996–1004 — 175 participants; "We observed no difference between the treatment strategies in time to stabilization… participants assigned to IPSRT in the acute treatment phase survived longer without a new affective episode (P = .01), irrespective of maintenance treatment assignment"; "Ability to increase regularity of social rhythms during acute treatment was associated with reduced likelihood of recurrence during the maintenance phase (P = .05)" — doi.org.
  10. Lam DH, Watkins ER, Hayward P, et al., "A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year," Archives of General Psychiatry 60(2), 2003, 145–152 — 103 patients; "During the 12-month period, the CT group had significantly fewer bipolar episodes, days in a bipolar episode, and number of admissions" — doi.org.
  11. Lam DH, Hayward P, Watkins ER, Wright K, Sham P, "Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2 years," American Journal of Psychiatry 162(2), 2005, 324–329 — "the effect of relapse prevention was mainly in the first year"; "cognitive therapy had no significant effect in relapse reduction over the last 18 months of the study period" — doi.org.
  12. Scott J, Paykel E, Morriss R, et al., "Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial," British Journal of Psychiatry 188, 2006, 313–320 — 253 patients; "More than half of the patients had a recurrence by 18 months, with no significant differences between groups (hazard ratio=1.05; 95% CI 0.74–1.50)"; "Post hoc analysis demonstrated a significant interaction (P=0.04) such that adjunctive CBT was significantly more effective than treatment as usual in those with fewer than 12 previous episodes, but less effective in those with more episodes" — doi.org.
  13. Miklowitz DJ, Otto MW, Frank E, et al., "Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program," Archives of General Psychiatry 64(4), 2007, 419–426 — 293 patients; "Patients receiving intensive psychotherapy had significantly higher year-end recovery rates (64.4% vs 51.5%) and shorter times to recovery than patients in collaborative care (hazard ratio, 1.47; 95% confidence interval, 1.08-2.00; P = .01)"; recovery by modality; "No statistically significant differences were observed in the outcomes of the 3 intensive psychotherapies"; "patients in the intensive psychotherapy group received a mean±SD of 14.3±11.4 of 30 protocol-specified sessions"; "the study was underpowered to detect small effect size differences between each of the intensive modalities" — pmc.ncbi.nlm.nih.gov.
  14. Harvey AG, Soehner AM, Kaplan KA, et al., "Treating insomnia improves mood state, sleep, and functioning in bipolar disorder: a pilot randomized controlled trial," Journal of Consulting and Clinical Psychology 83(3), 2015, 564–577 — 58 participants; "the CBTI-BP group had fewer days in a bipolar episode relative to the PE group (3.3 days vs. 25.5 days)… a significantly lower hypomania/mania relapse rate (4.6% vs. 31.6%) and a marginally lower overall mood episode relapse rate (13.6% vs. 42.1%)" — doi.org.
  15. National Institute for Health and Care Excellence, "Bipolar disorder: assessment and management," clinical guideline CG185 — recommendation 1.7.3 on structured psychological interventions with a published evidence-based manual; recommendation 1.7.4 on their required contents; recommendation 1.7.2 on offering a family intervention; recommendation 1.6.1 on psychological intervention in bipolar depression — nice.org.uk.
  16. National Institute for Health and Care Excellence, clinical guideline CG185, recommendation 1.4.1 — the risk management plan covering triggers, early warning signs, an agreed protocol and contacts — nice.org.uk.

Paid for by participating therapists. Inclusion is computed from availability data — never purchased. No ads, no data sold.